Premium
Drug‐induced prolongation of the QT interval: why the regulatory concern?
Author(s) -
Shah Rashmi R.
Publication year - 2002
Publication title -
fundamental and clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 73
eISSN - 1472-8206
pISSN - 0767-3981
DOI - 10.1046/j.1472-8206.2002.00082.x
Subject(s) - prolongation , regulatory agency , agency (philosophy) , qt interval , drug , pharmacology , medicine , business , political science , public administration , cardiology , sociology , social science
The views expressed in this paper are those of the author and do not necessarily represent the views or the opinions of Medicines Control Agency, other regulatory authorities or any of their advisory committees.